I know this will not happen, but I want to propose an idea. Whatever we get from the Amarex settlement should go towards a stock buy back. The original IPO was for $.75 a share and the shares outstanding was around 300mil. That really puts it in perspective as to what it has cost us to get here. Much of the fund raising went towards a BLA that is not going to happen, investors paid for something and what ever we get back for the failure to execute should go directly back to the investors. It makes me angry to think that a share price is ridiculous now because of the # of outstanding shares.

Cytodyn is now a phase 2 trial/ peer review stage company. this is much cheaper and smaller than a phase 3 about to make money on it's drug company. there is no reason to have over a billion shares outstanding. I think phase 2 companies are at the perfect stage to get partners to go for phase 3, it should have been done that way from the start.

A nice as it might seem to use the funds to do trials, I don't want this company to take the easy road and not partner. getting a phase 3 through the FDA even with a competent CRO is obviously difficult to put it mildly. We are not here to fix the system, we need to navigate it the way it is.

$80millin can buy back 400 million shares and get us under the billion shares outstanding. this will have a huge value add to share holders and ruin shorts.

What do all of you think?